<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00599482</url>
  </required_header>
  <id_info>
    <org_study_id>GAAD-SCC-CTP1</org_study_id>
    <nct_id>NCT00599482</nct_id>
  </id_info>
  <brief_title>Far Infrared Radiation for Sickle Cell Pain Management</brief_title>
  <official_title>Phase 1 Study to Examine the Use of Far Infrared Radiation for Pain Management During Sickle Cell Crisis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GAAD Medical Research Institute Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GAAD Medical Research Institute Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Most patients with sickle-cell disease have periodic intensely painful episodes. To manage
      this pain, we are proposing the drinking of at least 500 mL of water followed by far infrared
      radiation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Painful sickle cell crises are treated with hydration and analgesics. Ischemia is an absolute
      or relative shortage of the blood supply to an organ. Relative shortage means the mismatch of
      blood supply (oxygen delivery) and blood request for adequate oxygenation of tissue.

      It is hereby postulated that far infrared radiation of the body will promote blood and oxygen
      supply to the affected tissues. In addition, the analgesic properties of far infrared will
      alleviate pain due to the crisis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">January 2009</completion_date>
  <primary_completion_date type="Anticipated">September 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Management</measure>
    <time_frame>40 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Anemia, Sickle Cell</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Far Infrared Radiation</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Far Infrared Radiation (5μm to 20μm wavelength)</intervention_name>
    <description>Far infrared radiation for 30 to 40 minutes during each session.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  People with sickle cell disease

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ken Nedd, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>GAAD Medical Research Institute Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kwasi Donyina, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>GAAD Medical Research Institute Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Centre for Incurable Diseases</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5R 3G9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2008</study_first_submitted>
  <study_first_submitted_qc>January 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2008</study_first_posted>
  <last_update_submitted>January 2, 2009</last_update_submitted>
  <last_update_submitted_qc>January 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Kwasi Donyina/Founder and President</name_title>
    <organization>GAAD Medical Research Institute Inc.</organization>
  </responsible_party>
  <keyword>HEMOGLOBIN SC DISEASE</keyword>
  <keyword>HEMOGLOBIN C DISEASE</keyword>
  <keyword>SICKLE CELL TRAIT</keyword>
  <keyword>THALASSEMIA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

